Truist Maintains Buy Rating on Exponent (EXPO) While Cutting Price Target to $90
Exponent, Inc. (NASDAQ:EXPO) is included among the 15 Overlooked Dividend Stocks to Buy Right Now. Truist Maintains Buy Rating on Exponent (EXPO) While Cutting Price Target to $90 On November 2, Truist lowered its price target for Exponent, Inc. (NASDAQ:EXPO) from $100 to $90 while maintaining a Buy rating, according to a report by The Fly. The analyst noted that artificial intelligence could create new opportunities for the company as clients seek its expertise in failure analysis. However, ...